Philip Hirschhorn, Shareholder, Buchanan Ingersoll & Rooney PC to Speak at The Knowledge Group’s Paragraph IV Patent Litigation in the 2019 Landscape
TKG/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Philip Hirschhorn, Shareholder, Buchanan Ingersoll & Rooney PC will speak at TKG’s webcast entitled: “Paragraph IV Patent Litigation in the 2019 Landscape:Trends and Significant Developments Explored!” This event is scheduled for April 10, 2019 from 3:00 PM to 4:00 PM (ET).
- (1888PressRelease) March 12, 2019 - The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Philip L. Hirschhorn, Shareholder, Buchanan Ingersoll & Rooney PC will speak at the Knowledge Group’s webcast entitled: “Paragraph IV Patent Litigation in the 2019 Landscape: Trends and Significant Developments Explored!” This event is scheduled for Wednesday, April 10, 2019 from 3:00 PM to 4:00 PM (ET).
For further details, please visit:
https://www.theknowledgegroup.org/webcasts/paragraph-iv-patent-certifications-2/
About Philip L. Hirschhorn
Phil has more than 25 years' experience as an intellectual property (IP) trial lawyer. His extensive experience includes bench and jury trials and arbitrations. He has represented clients in Hatch-Waxman (Paragraph IV) litigations, has worked in diverse industries such as graphics, visualization technologies, medical device, chemical and consumer products, and also has experience handling copyright and trademark/trade dress litigation.
In patent litigation, Phil has counseled clients on the interplay between Patent Office and district court proceedings. He has represented clients involved in proceedings in or with the Patent Office, including § 145 actions to obtain patents, ex parte and inter partes reexaminations and, with the advent of the America Invents Act, adversarial post-grant proceedings, including inter partes reviews.
Phil is the managing shareholder for Buchanan's New York City office and the former co-chair of the firm's IP Section.
About Buchanan Ingersoll & Rooney PC
Buchanan is a national law firm with a strong reputation for providing progressive, industry-leading legal, business, regulatory and government relations advice to our regional, national and international clients. Our 450 attorneys and government relations professionals across 17 offices proudly represent some of the highest profile and innovative companies in the nation, including 50 of the Fortune 100. While we service a wide range of clients, Buchanan has especially deep experience in the energy, finance, healthcare and life sciences industries. We bring to our clients an intimate knowledge of the players, market forces and political and regulatory landscape and use our full-service offerings to protect, defend and advance our clients’ businesses.
Event Synopsis:
In recent years, generic drug manufacturers have been grappling with filing Paragraph IV (PIV) challenges to successfully gain market entry. The significant increase in the number of patent challenges on brand drugs, specifically on blockbuster drugs, is expected to continue in 2019. However, with the evolving regulatory paradigm, manufacturers become vulnerable to a myriad of risks, including the potential for a PIV lawsuit.
In the changing PIV landscape, it is imperative that pharmaceutical companies are abreast of the latest PIV filings as well as significant developments to avoid patent infringement, more so, the complexities of a PIV litigation. They must be well-versed with the litigation know-hows to efficiently and effectively win a PIV dispute.
Listen as a panel of distinguished professionals and thought leaders assembled by The Knowledge Group provide an in-depth discussion of the significant trends and developments in Paragraph IV Patent Certifications. Speakers will also offer best strategies that will help manufacturers and counsel in this evolving landscape.
Key issues that will be covered in this course are:
• Paragraph IV Patent Certifications and the Abbreviated New Drug Application (ANDA): Recent Trends and Developments
• PIV Certification Filings
• Overcoming Application Hurdles and Risks
• Notable PIV Cases and Court Rulings
• Best Application Strategies
• Significant Litigation Techniques
• What Lies Ahead
About The Knowledge Group/The Knowledge Congress Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam